Reported Aug 13, 2025 · Ongoing

Doxepin Hydrochloride Capsules, USP, 10 mg, 100 Capsules, Rx only, Manufactured by: Alembic Pharmaceuticals Limited,…

Alembic Pharmaceuticals Limited

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Alembic Pharmaceuticals Limited · Formulation Division, Village Panelav, P.O. Tajpura, Near Baska, Taluka Halol · Panchmahal, N/A · N/A

Is this the product you have?

  • Doxepin Hydrochloride Capsules, USP, 10 mg, 100 Capsules, Rx only
  • Manufactured byAlembic Pharmaceuticals Limited, Panela v 389350, Gujarat, India
  • Manufactured forAlembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-637-31
Lot codes and dates
  • Lot2305015142, Exp
  • Date9/30/2025
Amount recalled
9,492 bottles

Where it was sold

  • Nationwide

Why it was recalled

CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Alembic Pharmaceuticals Limited recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Data as of Sep 19, 8:07 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.